Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PennantPark Investment Advisers is an alternative asset management and investment advisory firm focused on middle-market credit and private capital rather than biotechnology or healthcare product development. The firm provides financing solutions across the capital structure through business development companies, private capital funds, joint ventures, and other specialized funds. Its activities center on direct lending, mezzanine lending, leveraged finance, structured credit, and related investment strategies for middle-market companies. For a biotech analyst, the key takeaway is that this is a financial services and credit-investing firm, not a drug developer, healthcare operator, or life sciences tools company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PennantPark Investment Advisers.